Condition
Mesothelioma
Estimated Enrollment: 126
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: No masking|Primary Purpose: Treatment
Study ID Numbers: I227|2016-002286-60
Study First Received: May 24, 2016
Last Updated: March 27, 2017
Estimated Primary Completion Date: May 2019
Primary Outcome Measures:
Progression free survival measured as time from randomization to first observation of objective disease relapse or progression|Number and severity of adverse events|Overall Survival|Quality of Life using EORTC QLQ-C30|Response rate compared using Fisher’s exact test
Sponsors and Collaborators:
Canadian Cancer Trials Group|National Cancer Institute, Naples|Merck Sharp & Dohme Corp.
Website Link: https://ClinicalTrials.gov/show/NCT02784171
